Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway

BACKGROUND: Isorhapontigenin (ISO) has been shown to have antioxidant activity. This study aimed to investigate the antioxidant effects of ISO on cerebral ischemia/reperfusion (I/R) injury and its possible molecular mechanisms. METHODS: Focal cerebral ischemia‐reperfusion injury (MCAO/R) model and p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Behav
Autors principals: Xue, Zhe, Zhao, Kai, Sun, Zhenghui, Wu, Chen, Yu, Bowen, Kong, Dongsheng, Xu, Bainan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323036/
https://ncbi.nlm.nih.gov/pubmed/34102010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.2143
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars